Biosimulytics

Description

Biosimulytics uses computational crystal structure prediction to map a molecule's solid-form landscape, predict competing polymorphs, and guide focused experimental screening for drug development decisions and formulation selection.

Biosimulytics is located in the Dublin ecosystem.

Related

• SyngensysSyngensys develops synthetic gene promoters using transcriptional landscape analysis, computational design, selection, and validation to…
• NexMRNexMR provides light-coupled Photo-CIDNP NMR that uses illumination to hyperpolarize small molecules in water at room temperature,…
• OncolinesOncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms,…
• Nanoform Finland OyjNanoform Finland Oyj builds nanotechnology-enabled formulation and GMP manufacturing processes to improve bioavailability and drug loading…
• Rab DiagnosticsRab Diagnostics develops biomarker tools, assays and the RabCANCER platform to predict antibody–drug conjugate response for pharma…
• bit.biobit.bio provides deterministically programmed human iPSC-derived cells and CRISPR screening services for research and drug discovery,…
• APCAPC provides process development services and technology platforms that accelerate pharmaceutical and biologics development for pharma and…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
• Prevision MedicinePrevision Medicine tests living cancer and healthy cells from a patient biopsy against 100+ drugs and combinations using a patented ex vivo…